175 related articles for article (PubMed ID: 17309042)
1. Entry of two new asymmetric bispyridinium oximes (K-27 and K-48) into the rat brain: comparison with obidoxime.
Lorke DE; Hasan MY; Nurulain SM; Sheen R; Kuca K; Petroianu GA
J Appl Toxicol; 2007; 27(5):482-90. PubMed ID: 17309042
[TBL] [Abstract][Full Text] [Related]
2. Five oximes (K-27, K-48, obidoxime, HI-6 and trimedoxime) in comparison with pralidoxime: survival in rats exposed to methyl-paraoxon.
Petroianu GA; Nurulain SM; Nagelkerke N; Shafiullah M; Kassa J; Kuca K
J Appl Toxicol; 2007; 27(5):453-7. PubMed ID: 17304644
[TBL] [Abstract][Full Text] [Related]
3. Paraoxon has only a minimal effect on pralidoxime brain concentration in rats.
Petroianu GA; Lorke DE; Hasan MY; Adem A; Sheen R; Nurulain SM; Kalasz H
J Appl Toxicol; 2007; 27(4):350-7. PubMed ID: 17265425
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI-6.
Lorke DE; Hasan MY; Nurulain SM; Kuca K; Schmitt A; Petroianu GA
Toxicol Mech Methods; 2009 May; 19(4):327-33. PubMed ID: 19778224
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K
Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
[TBL] [Abstract][Full Text] [Related]
6. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.
Petroianu GA; Arafat K; Nurulain SM; Kuca K; Kassa J
J Appl Toxicol; 2007; 27(2):168-75. PubMed ID: 17265452
[TBL] [Abstract][Full Text] [Related]
7. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon.
Petroianu GA; Nurulain SM; Nagelkerke N; Al-Sultan MA; Kuca K; Kassa J
J Appl Toxicol; 2006; 26(3):262-8. PubMed ID: 16583462
[TBL] [Abstract][Full Text] [Related]
8. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
Petroianu GA; Arafat K; Kuca K; Kassa J
J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529
[TBL] [Abstract][Full Text] [Related]
9. Partition of bispyridinium oximes (trimedoxime and K074) administered in therapeutic doses into different parts of the rat brain.
Karasova JZ; Zemek F; Bajgar J; Vasatova M; Prochazka P; Novotny L; Kuca K
J Pharm Biomed Anal; 2011 Apr; 54(5):1082-7. PubMed ID: 21146949
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
[TBL] [Abstract][Full Text] [Related]
11. Eight new bispyridinium oximes in comparison with the conventional oximes pralidoxime and obidoxime: in vivo efficacy to protect from diisopropylfluorophosphate toxicity.
Lorke DE; Nurulain SM; Hasan MY; Kuca K; Musilek K; Petroianu GA
J Appl Toxicol; 2008 Oct; 28(7):920-8. PubMed ID: 18548743
[TBL] [Abstract][Full Text] [Related]
12. Time-dependent changes in concentration of two clinically used acetylcholinesterase reactivators (HI-6 and obidoxime) in rat plasma determined by HPLC techniques after in vivo administration.
Zdarova Karasova J; Novotny L; Antos K; Zivna H; Kuca K
Anal Sci; 2010 Jan; 26(1):63-7. PubMed ID: 20065589
[TBL] [Abstract][Full Text] [Related]
13. Formation and disposition of diethylphosphoryl-obidoxime, a potent anticholinesterase that is hydrolyzed by human paraoxonase (PON1).
Kiderlen D; Eyer P; Worek F
Biochem Pharmacol; 2005 Jun; 69(12):1853-67. PubMed ID: 15876422
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of eight experimental bispyridinium oximes against paraoxon-induced mortality: comparison with the conventional oximes pralidoxime and obidoxime.
Nurulain SM; Lorke DE; Hasan MY; Shafiullah M; Kuca K; Musilek K; Petroianu GA
Neurotox Res; 2009 Jul; 16(1):60-7. PubMed ID: 19526299
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the neuroprotective efficacy of newly developed oximes (K206, K269) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
Kassa J; Karasova JZ; Bajgar J; Tesarova S; Kuca K; Musilek K
Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):228-35. PubMed ID: 19143747
[TBL] [Abstract][Full Text] [Related]
16. Comments on "Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI 6".
Theirmann H; Worek F; Eyer P
Toxicol Mech Methods; 2009 May; 19(4):334; author reply 335. PubMed ID: 19778225
[No Abstract] [Full Text] [Related]
17. Pharmacokinetic study of two acetylcholinesterase reactivators, trimedoxime and newly synthesized oxime K027, in rat plasma.
Karasova JZ; Chladek J; Hroch M; Josef F; Hnidkova D; Kuca K
J Appl Toxicol; 2013 Jan; 33(1):18-23. PubMed ID: 21717485
[TBL] [Abstract][Full Text] [Related]
18. New K-Oximes (K-27 and K-48) in Comparison with Obidoxime (LuH-6), HI-6, Trimedoxime (TMB-4), and Pralidoxime (2-PAM): Survival in Rats Exposed IP to the Organophosphate Paraoxon.
Petroianu GA; Hasan MY; Nurulain SM; Nagelkerke N; Kassa J; Kuca K
Toxicol Mech Methods; 2007; 17(7):401-8. PubMed ID: 20020943
[TBL] [Abstract][Full Text] [Related]
19. Effect of five acetylcholinesterase reactivators on tabun-intoxicated rats: induction of oxidative stress versus reactivation efficacy.
Pohanka M; Karasova JZ; Musilek K; Kuca K; Kassa J
J Appl Toxicol; 2009 Aug; 29(6):483-8. PubMed ID: 19338015
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of obidoxime in patients poisoned with organophosphorus compounds.
Thiermann H; Eyer F; Felgenhauer N; Pfab R; Zilker T; Eyer P; Worek F
Toxicol Lett; 2010 Sep; 197(3):236-42. PubMed ID: 20542100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
